Fonseca, I.C.F.; Pais, M.L.; Rodrigues, F.M.S.; Sereno, J.; Castelo-Branco, M.; Cavadas, C.; Pereira, M.M.; Abrunhosa, A.J.
Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies. Pharmaceuticals 2024, 17, 474.
https://doi.org/10.3390/ph17040474
AMA Style
Fonseca ICF, Pais ML, Rodrigues FMS, Sereno J, Castelo-Branco M, Cavadas C, Pereira MM, Abrunhosa AJ.
Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies. Pharmaceuticals. 2024; 17(4):474.
https://doi.org/10.3390/ph17040474
Chicago/Turabian Style
Fonseca, Inês C. F., Mariana Lapo Pais, Fábio M. S. Rodrigues, José Sereno, Miguel Castelo-Branco, Cláudia Cavadas, Mariette M. Pereira, and Antero J. Abrunhosa.
2024. "Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies" Pharmaceuticals 17, no. 4: 474.
https://doi.org/10.3390/ph17040474
APA Style
Fonseca, I. C. F., Pais, M. L., Rodrigues, F. M. S., Sereno, J., Castelo-Branco, M., Cavadas, C., Pereira, M. M., & Abrunhosa, A. J.
(2024). Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies. Pharmaceuticals, 17(4), 474.
https://doi.org/10.3390/ph17040474
